Alcon to Participate in Bank of America Merrill Lynch and Jefferies Healthcare Conferences
April 25 2019 - 4:00PM
Business Wire
Regulatory News:
Alcon (SIX: ALC) (NYSE: ALC), the global leader in eye care
dedicated to helping people see brilliantly, today announced it
will participate in the following conferences:
May 14, 2019Bank of America Merrill Lynch Healthcare
ConferenceLas Vegas
June 5, 2019Jefferies 2019 Global Healthcare ConferenceNew York
City
Alcon CEO David Endicott and CFO Tim Stonesifer will speak at
both conferences. Presentation materials will be provided on
Alcon’s investor website at www.investor.alcon.com.
Disclaimer
This communication does not constitute an offer or invitation to
subscribe for or purchase any securities of Alcon. This publication
may contain certain forward-looking statements concerning the
Company and its business. Such statements involve certain risks,
uncertainties and other factors which could cause the actual
results, financial condition, performance or achievements of the
Company to be materially different from those expressed or implied
by such statements. Readers should therefore not place undue
reliance on these statements, particularly not in connection with
any contract or investment decision. The Company disclaims any
obligation to update these forward-looking statements.
About Alcon
Alcon helps people see brilliantly. As the global leader in eye
care with a heritage spanning more than seven decades, we offer the
broadest portfolio of products to enhance sight and improve
people’s lives. Our Surgical and Vision Care products touch the
lives of more than 260 million people in over 140 countries each
year living with conditions like cataracts, glaucoma, retinal
diseases and refractive errors. Our more than 20,000 associates are
enhancing the quality of life through innovative products,
partnerships with eye care professionals and programs that advance
access to quality eye care. Learn more at www.alcon.com.
Connect with us onFacebookLinkedIn
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190425005886/en/
Investor RelationsChristina
Cheng+ 41 589 112 110 (Geneva)+ 1 817 615 2789 (Fort
Worth)investor.relations@alcon.com
Media RelationsWes Warnock+
41 589 112 111 (Geneva)+ 1 817 615 2501 (Fort
Worth)globalmedia.relations@alcon.com
Alcon (NYSE:ALC)
Historical Stock Chart
From May 2024 to Jun 2024
Alcon (NYSE:ALC)
Historical Stock Chart
From Jun 2023 to Jun 2024